Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

342.41
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
244.28
Today|||52-Week Range
348.84
+7.48%
Year-to-Date
Catawba Capital Management Buys Automatic Data Processing Inc, Parker Hannifin Corp,...
Jan 19 / GuruFocus News - Paid Partner Content
3 Pharma and Biotech Stocks to Watch Out for in 2018
Jan 15 / Zacks.com - Paid Partner Content
M&A Rumors Rise Again
Jan 19 / TheStreet.com - Paid Partner Content
Roche MS Drug Ocrevus Gets Marketing Authorization in Europe
Jan 15 / Zacks.com - Paid Partner Content
Five Cheap Stocks With Growing Book Value
Jan 18 / GuruFocus News - Paid Partner Content
Top Stock Reports for Home Depot, CVS Health & Biogen
Jan 12 / Zacks.com - Paid Partner Content
Charter Trust Co Buys iShares Core MSCI Emerging Markets, The Home Depot Inc, iShares...
Jan 17 / GuruFocus News - Paid Partner Content
Big Pharma CEOs Speak About Impact of Tax Reform on M&A
Jan 11 / Zacks.com - Paid Partner Content
Legacy Private Trust Co. Buys iShares 20+ Year Treasury Bond ETF, SPDR Bloomberg Barc...
Jan 16 / GuruFocus News - Paid Partner Content
Stock Market News For Jan 9, 2018
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close342.41
Today’s open347.57
Day’s range341.82 - 347.57
Volume1,232,214
Average volume (3 months)1,227,700
Market cap$72.4B
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+8.81%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+9.37%
P/E ratio21.0
Price/Sales6.09
Price/Book6.09

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc0.000.00%
GILDGilead Sciences0.000.00%
----
BIVVBioverativ Inc0.000.00%
Data as of 4:15pm ET, 01/19/2018

Financials

Next reporting dateJanuary 25, 2018
EPS forecast (this quarter)$5.45
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts